- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aurisco Pharmaceutical Co Ltd (605116)
The Aurisco Pharmaceutical Co share price today is 19.64, view SS 605116 stock exchange data. Track the latest Aurisco Pharmaceutical Co share price with real-time updates on 605116 stock performance including market cap, day range, 52-week range and dividend yield. Access 605116 charts, earnings dates and analyst estimates to support your investment decisions.
Shanghai
Currency in CNY
19.64
-0.16(-0.81%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.57
19.97
52 wk Range
18.09
35.58
605116 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.5719.97
52 wk Range
18.0935.58
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.72%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.72%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
605116 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has maintained dividend payments for 6 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
28-08-2026
EPS / Forecast
0.23 / --
Revenue / Forecast
439.11M / --
Compare 605116 to Peers and Sector
Metrics to compare | 605116 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship605116PeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.5x | 27.9x | −0.4x | |
PEG Ratio | −2.12 | 0.31 | 0.00 | |
Price/Book | 3.0x | 2.8x | 2.6x | |
Price / LTM Sales | 4.7x | 4.4x | 3.1x | |
Upside (Analyst Target) | 42.6% | 36.3% | 49.6% | |
Fair Value Upside | Unlock | 13.9% | 7.1% | Unlock |
Aurisco Pharmaceutical Co.,Ltd. engages in the research, development, production and sales of special complex APIs, pharmaceutical intermediates and preparations worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs. It also provides eplerenone, an API to treat cardiovascular diseases, lowering blood pressure, and treating heart failure; futicasone propionate, used for the treatment of asthma, respiratory tract diseases, and rhinitis; Tenofovir, an anti-infection used to treat AIDS and hepatitis B; pregabalin for the treatment of anti-epileptic, analgesic, and anti-anxiety purposes, as well as for neuralgia; abiraterone acetate to treat prostate cancer; and dydrogesterone, to treat endogenous for women’s heath. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Aurisco Pharmaceutical Co (605116) Share Price Today?
The Aurisco Pharmaceutical Co share price today is 19.64.
What is the current Aurisco Pharmaceutical Co (605116) share price and day range?
As of 04-09-2026, the Aurisco Pharmaceutical Co share price is 19.64, with a previous close of 19.80. The share price has ranged from 19.57 to 19.97 today, while the 52-week range spans from 18.09 to 35.58.
What Is the Aurisco Pharmaceutical Co Market Cap?
As of today, Aurisco Pharmaceutical Co market cap is 7.99B.
Does Aurisco Pharmaceutical Co Pay Dividends? What's The Current Dividend Yield?
The Aurisco Pharmaceutical Co dividend yield is 1.72%.
What Is Aurisco Pharmaceutical Co's Earnings Per Share (TTM)?
The Aurisco Pharmaceutical Co EPS (TTM) is 0.91.
When Is the Next Aurisco Pharmaceutical Co Earnings Date?
Aurisco Pharmaceutical Co will release its next earnings report on 04-11-2026.
From a Technical Analysis Perspective, Is 605116 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Aurisco Pharmaceutical Co Trade On?
Aurisco Pharmaceutical Co is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Aurisco Pharmaceutical Co?
The stock symbol for Aurisco Pharmaceutical Co is "605116."
How Many Times Has Aurisco Pharmaceutical Co Stock Split?
Aurisco Pharmaceutical Co has split 0 times.
How Many Employees Does Aurisco Pharmaceutical Co Have?
Aurisco Pharmaceutical Co has 2026 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.